BioSpace News Archive

AdaptHealth Corp. announced today that AdaptHealth granted restricted stock units covering 553,251 shares of the Company’s common stock at target performance levels (the “Inducement RSUs”) to Suzanne Foster, AdaptHealth’s newly appointed Chief Executive Officer.

One of the most frequently diagnosed cancers worldwide accounts for breast cancer with respect to its high prevalence and fatalities gaits.

AdaptHealth Corp. announced today that they will participate in the Goldman Sachs 45th Annual Global Healthcare Conference, being held in Miami, on Wednesday, June 12, 2024, including a presentation at 9:20am ET.

NeoMab Biotechnology Co., Ltd. celebrated its grand opening in Suzhou Industrial Park.

Matica Biotechnology (Matica Bio) announced today that it will participate in the world’s largest biotech exhibition, the BIO International Convention (BIO USA).

Allez Health Inc., formerly known as Zense-Life Inc., an emerging biosensor venture founded by proven experts in the continuous glucose monitoring space, announced a $60 million Series A+ financing.

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, today announced the signing of a definitive agreement to acquire Mirus Bio for US$ 600 million.

Connect Biopharma Holdings Limited announced that Edward Kerwin, M.D. presented a late-breaking poster presentation on the positive results from the rademikibart global Phase 2b trial in patients with moderate-to-severe asthma at the American Thoracic Society 2024 International Conference, taking place May 17-22, 2024 in San Diego, CA.

Inventiva announced that two scientific abstracts have been selected for poster presentation at the upcoming International Liver Congress™ 2024 hosted by the European Association for the Study of the Liver on June 5-8, 2024 in Milan, Italy.

Standard BioTools Inc. (“Standard BioTools”) (Nasdaq:LAB) today announced that its management team will participate in the following investor conferences in the month of June.